Life Changing Daily Pill that Fights Cancer and Autoimmune Diseases

Invest Now for a Limited Time

Trethera News

Gloved hand of a scientist in a lab writing on a digital stilus with a digital pen.

Blue DNA illustration

Photo of a series of test tubes.

Scientific microscope with visual representation of DNA helix

Trethera Announces Poster Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

January 24, 2023

Trethera Announces Appointment of R. Boyd Quinnell to Board of Directors

January 18, 2023

Trethera Receives $1.6 Million National Eye Institute Grant for Continued Advancement of TRE-515 Optic Neuritis Program

October 19, 2022

Trethera Announces Multiple Sclerosis Treatment Poster Presentation at the American Neurological Association Annual Meeting

October 4, 2022

U.S. Patent Office Issues Trethera Composition of Matter Patent Covering TRE-515, Extending Market Exclusivity to Late 2041

September 20, 2022